Related Experiment Video
Updated: Feb 6, 2026

The Mouse Stroke Unit Protocol with Standardized Neurological Scoring for Translational Mouse Stroke Studies
Published on: February 7, 2025
Oxidized low-density lipoprotein predicts recurrent stroke in patients with minor stroke or TIA
Anxin Wang1, Jie Xu1, Guojuan Chen1
1From the Department of Neurology (A.W., J.X., X.M., J.L., H.L., N.Z., C.M., L.D., X.Z., L.L., Y.W., Y.W.), Beijing Tiantan Hospital, and Department of Epidemiology and Health Statistics (A.W.), School of Public Health, Capital Medical University; China National Clinical Research Center for Neurological Diseases (A.W., J.X., X.M., J.L., H.L., N.Z., C.M., L.D., X.Z., L.L., Y.W., Y.W.); Center of Stroke, Beijing Institute for Brain Disorders (A.W., J.X., X.M., J.L., H.L., N.Z., C.M., L.D., X.Z., L.L., Y.W., Y.W.); Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease (A.W., J.X., X.M., J.L., H.L., N.Z., C.M., L.D., X.Z., L.L., Y.W., Y.W.); Department of Neurology (G.C., Y.C.), Tangshan Gongren Hospital, North China University of Science and Technology, Tangshan, China; INI Stroke Network (D.W.), OSF Healthcare System, University of Illinois College of Medicine, Peoria; and Dell Medical School (S.C.J.), University of Texas, Austin.
Objective:
To investigate the association between oxidized low-density lipoprotein (oxLDL) and recurrent stroke in patients with minor stroke or TIA.
Methods:
In the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events (CHANCE) trial, baseline oxLDL levels were blindly measured in plasma with the 4E6 antibody in the core laboratory. The primary outcome was any stroke within 90 days. The secondary outcomes included any stroke within 1 year and ischemic stroke and combined vascular events within 90 days and 1 year. The associations of oxLDL with recurrent stroke were analyzed by Cox proportional hazards.
Results:
Among 3,019 patients included in this study, the median (interquartile range) of oxLDL was 13.96 (6.65-28.81) μg/dL. After adjustment for conventional confounding factors, patients in the highest oxLDL quartile (≥28.81 μg/dL) had a higher risk of recurrent stroke within 90 days (hazard ratio 1.43, 95% confidence interval 1.03-1.98) compared to those in the lowest oxLDL quartile (<6.65 μg/dL). Similar results were found for secondary outcomes. We also found a J-shaped association between oxLDL and risk of each outcome. There were no significant interactions between oxLDL and low-density lipoprotein and use of dual antiplatelet, antihypertensive, antidiabetic, and statins agents.
Conclusions:
Elevated oxLDL levels can independently predict recurrent stroke in patients with minor stroke or TIA.
Clinicaltrialsgov Identifier:
NCT00979589.
Related Concept Videos
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Cardiac Output and Stroke Volume
In an average resting adult male, the typical cardiac...
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Minor Losses in Pipes
Valves play a significant role in generating minor losses by obstructing or redirecting the fluid flow. When a valve is closed or partially closed, it restricts the flow...
Oxidation Numbers
Predicting Molecular Geometry

